Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Macrophage TREM2 is a triglyceride-rich lipoprotein receptor that undergoes shedding in prediabetic hepatic steatosis
Jingjing Tang, Jenny E. Kanter, Baohai Shao, Masami Shimizu-Albergine, Farah Kramer, Ah Reum Khang, Jason Luo, Huaqing Zheng, Alan Tran, Jocelyn Cervantes, Jeremy M. Frey, Mauricio D. Dorfman, Cheng-Chieh Hsu, Laura J. den Hartigh, Tomas Vaisar, Brandon S.J. Davies, Adam E. Mullick, George N. Ioannou, Gordon I. Smith, Samuel Klein, Nicholas O. Davidson, Karin E. Bornfeldt
Jingjing Tang, Jenny E. Kanter, Baohai Shao, Masami Shimizu-Albergine, Farah Kramer, Ah Reum Khang, Jason Luo, Huaqing Zheng, Alan Tran, Jocelyn Cervantes, Jeremy M. Frey, Mauricio D. Dorfman, Cheng-Chieh Hsu, Laura J. den Hartigh, Tomas Vaisar, Brandon S.J. Davies, Adam E. Mullick, George N. Ioannou, Gordon I. Smith, Samuel Klein, Nicholas O. Davidson, Karin E. Bornfeldt
View: Text | PDF
Research Article Metabolism Vascular biology

Macrophage TREM2 is a triglyceride-rich lipoprotein receptor that undergoes shedding in prediabetic hepatic steatosis

  • Text
  • PDF
Abstract

Prediabetes is associated with increased production of triglyceride-rich lipoproteins (TRLs), cardiovascular disease (CVD), and hepatic steatosis, which is linked to increased plasma levels of soluble TREM2 (sTREM2), the shed domain of TREM2 (triggering receptor expressed on myeloid cells 2). Whether and how TREM2 shedding contributes to elevated TRLs is unknown. By complementary analyses of individuals with prediabetes and hepatic steatosis and preclinical models, we show that plasma sTREM2 levels correlate positively with plasma apolipoprotein C3 (APOC3), an apolipoprotein that slows TRL catabolism and predicts CVD risk. Individuals with prediabetes and hepatic steatosis had higher plasma concentrations of APOC3-rich TRLs 35 to 60 nm in diameter than healthy controls. Mouse models of prediabetes with hepatic steatosis revealed that the increased plasma concentrations of sTREM2, APOC3, and TRLs were due to activation of macrophage ADAM17, a TREM2 sheddase. Preserving macrophage full-length TREM2 protected against the elevated plasma APOC3, sTREM2, dyslipidemia, and atherosclerosis, whereas TREM2 deficiency increased APOC3, TRLs, and atherosclerosis. Mechanistically, full-length TREM2 mediates macrophage TRL uptake, preventing excessive hepatic APOC3-rich TRL release and atherosclerosis. Our findings identify macrophage TREM2 shedding as an upstream contributor to the elevated TRLs in hepatic steatosis, providing a mechanistic link between hepatic steatosis and CVD risk in prediabetes.

Authors

Jingjing Tang, Jenny E. Kanter, Baohai Shao, Masami Shimizu-Albergine, Farah Kramer, Ah Reum Khang, Jason Luo, Huaqing Zheng, Alan Tran, Jocelyn Cervantes, Jeremy M. Frey, Mauricio D. Dorfman, Cheng-Chieh Hsu, Laura J. den Hartigh, Tomas Vaisar, Brandon S.J. Davies, Adam E. Mullick, George N. Ioannou, Gordon I. Smith, Samuel Klein, Nicholas O. Davidson, Karin E. Bornfeldt

×

Figure 4

Lack of macrophage TREM2 interaction with hepatocytes drives triglyceride, APOC3, and APOB100 secretion from steatotic hepatocytes.

Options: View larger image (or click on image) Download as PowerPoint
Lack of macrophage TREM2 interaction with hepatocytes drives triglycerid...
(A) Coculture model. Blue nuclei indicate Hoechst 33342–labeled hepatocytes. (B–F) Hepatocytes were isolated from Ldlr–/– mice labeled with Hoechst 33342 and immediately cocultured for 20 hours with and without BMDMs from WT mice, myeloid-targeted ADAM17M–/– mice, Trem2–/– mice, and mice deficient in both TREM2 and myeloid ADAM17 in the presence of oleic acid (OA) bound to BSA or with BSA alone. Cell-surface TREM2 (B) and lipid loading (BODIPY) of macrophages (C) were analyzed by flow cytometry. TGs, APOC3, and APOB100 in the conditioned media were measured by colorimetric assays and ELISAs (D–F). (G–I) Ldlr–/– mice were transplanted with BM from WT mice, ADAM17M–/– mice, and ADAM17M–/– Trem2–/– mice. After 7 weeks of recovery, the mice were fed DDC for 18 weeks, and plasma sTREM2, APOC3, and APOB100 were measured. Statistical analyses: 2-way ANOVA with Tukey’s multiple-comparison test (B–D), 2-way ANOVA with Šídák’s multiple-comparison test (E and F), Kruskal-Wallis with Dunn’s multiple-comparison test (G and I), 1-way ANOVA with Tukey’s multiple-comparison test (H). See Supporting Data Values for group sizes and statistics.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts